arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ACRO BIOMEDICAL CO., LTD.

ACBM

— Price unavailable

12 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

ACRO BIOMEDICAL CO., LTD. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC 39.8% ↗

FCF / Share —

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-101.15K

↓ -139.1% —

Operating Margin Operating profit as % of sales

-19.0%

↑ +91.3% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Revenue Growth YoY (%)	—	—	N/M	-45.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1000%)	74.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1381%)	255.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5009%)	-97.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-2052%)	1471.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+29329%)	—	—	—	—
Net Income Growth YoY (%)	-139.1% Weak ↓ Weak Declining Year-over-year change in net income	99.5% Excellent ↑ Excellent Improving Year-over-year change in net income	44.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-106.2% Weak ↑ Weak Improving Year-over-year change in net income	-6454.0% Weak Weak Year-over-year change in net income	68.4% Excellent Excellent Year-over-year change in net income	N/M	N/M	94.8% Excellent Excellent Year-over-year change in net income	8.6% Fair Fair Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	—	—	—	50.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-46.9% Weak Weak Compound annual revenue growth over 3 years	10.5% Good Good Compound annual revenue growth over 3 years	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	5.2% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-19.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-258%)	-218.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1920%)	6.4% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-46%)	-0.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-104%)	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	-17.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-313%)	-192.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2500%)	5.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-35%)	-0.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-106%)	—	—	—
FCF Margin (%) (%)	—	—	—	-22.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-29.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-30.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-90.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	1.94x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	206.11x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Return on Invested Capital (%)	39.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	12.9% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	3425.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-3262.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-944.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	32.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-231.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-1092.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-118.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15060.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2308.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1010.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	34.8% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	1714.5% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	26.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+74%)	14.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—	—	-17.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-42.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-384%)	33.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+125%)	-0.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	293.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1857%)	-165.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1206%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Interest Coverage (x)	—	—	-2746.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9302.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8615.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	-122.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	$-1.47K	$-1.15K	$-36.81K	$-2.53K	$-27.27K	$-3.92K

📊 What does each share earn? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Basic EPS, GAAP (USD)	—	—	—	—	$-0.14	$0.00	—	—	—	—	—	—
Book Value per Share (USD)	$-0.01	$-0.00	$-0.00	$0.01	$0.01	$0.01	$0.02	$0.03	$0.01	$-0.00	$0.00	—
Tangible Book Value per Share (USD)	$-0.01	$-0.00	$-0.00	$0.01	$0.01	$0.01	$0.02	$0.03	$0.01	$-0.00	$0.00	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Working Capital (USD)	$-386.96K	$-321.87K	$-286.95K	$456.42K	$614.76K	$661.17K	$767.93K	$1.24M	$511.33K	$-14.79K	$28.64K	—
Total Equity (USD)	$-386.96K	$-294.97K	$-257.01K	$486.37K	$643.71K	$685.87K	$873.67K	$1.24M	$511.33K	$-14.79K	$28.64K	$3.92K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$658.50K	$1.20M	$687.96K	$193.54K	$8.01M	$510.00K	—	—	—
Net Income, GAAP (USD)	$-101.15K	$-42.30K	$-8.81M	$-15.87M	$-7.70M	$-117.45K	$-371.60K	$419.66K	$-2.25K	$-43.43K	$-47.49K	—
Operating Cash Flow (USD)	$-196.30K	$-36.69K	$-15.45K	$-147.48K	$299.33K	$-199.46K	$-59.71K	$-140.42K	$-463.34K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 47 quarters

ACRO BIOMEDICAL CO., LTD.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACBM with peers